Skip to main content

Table 1 Characteristics of the study cohort (n = 576)

From: Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients

Characteristics Data
Age at baseline, years 53.93 ± 9.20
Sex, male, % 456 (79.17%)
Duration between LT and SRL initiation, months 15.70 ± 33.5
eGFR at baseline, ml/min/1.73 m2 78.60 ± 42.94
SCr at baseline, mg/dL 1.16 ± 0.72
Positive proteinuria at baseline (n = 535), n (%) 75 (14.02%)
Indications for liver transplantation, n (%) a
 Decompensated liver cirrhosis
  Hepatitis B 317 (55.03%)
  Hepatitis C 162 (28.13%)
  Alcoholic 87 (15.10%)
 HCC 318 (55.21%)
 Acute liver failure 34 (5.9%)
Baseline comorbidities, n (%)
 Congestive heart failure 3 (0.52%)
 Diabetes mellitus 144 (25%)
 Celebrovascular disease 5 (0.87%)
 Chronic pulmonary disease 26 (4.52%)
 Renal disease 21 (3.65%)
CNI use at baseline 520 (90.28%)
Plasma trough level of SRL, ng/mL
 <3 months, 6.19 ± 3.52
 3-6 months 6.26 ± 2.96
 6-12 months 6.19 ± 2.88
Duration of follow-up, day, (n = 574) 1075 ± 871.2
  1. Data presents as mean ± SD for continuous data, and n (%) for categorical data
  2. aNot excluding events